Imaging selection for reperfusion therapy in acute ischemic stroke beyond the conventional time window.
Lauranne ScheldemanAnke WoutersRobin LemmensPublished in: Journal of neurology (2021)
Originally, the efficacy of acute ischemic stroke treatment with thrombolysis or thrombectomy was only proven in narrow time windows of, respectively, 4.5 and 6 h after onset. Introducing imaging-based selection beyond non-contrast enhanced computed tomography has expanded the treatment window, focusing on presumed tissue status rather than solely on time after stroke onset. Different mismatch concepts have been adopted in clinical practice to select patients in the extended and unknown time window based on findings from randomized controlled trials. Since various concepts exist that can identify patients likely to benefit from reperfusion strategies, clinicians may wonder which imaging modality may be preferred in the emergency setting. In this review, we will discuss the different mismatch concepts and their practical implementation for patient selection for thrombolysis or thrombectomy, beyond the conventional time window.
Keyphrases
- acute ischemic stroke
- computed tomography
- contrast enhanced
- high resolution
- end stage renal disease
- magnetic resonance imaging
- ejection fraction
- newly diagnosed
- clinical practice
- prognostic factors
- clinical trial
- primary care
- public health
- palliative care
- photodynamic therapy
- mass spectrometry
- case report
- positron emission tomography
- stem cells
- patient reported outcomes
- percutaneous coronary intervention
- pet ct